Edition:
United States

Rigel Pharmaceuticals Inc (RIGL.OQ)

RIGL.OQ on NASDAQ Stock Exchange Global Select Market

2.38USD
4:00pm EDT
Change (% chg)

$-0.01 (-0.42%)
Prev Close
$2.39
Open
$2.43
Day's High
$2.43
Day's Low
$2.36
Volume
181,518
Avg. Vol
239,001
52-wk High
$4.37
52-wk Low
$1.94

Chart for

About

Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases. The Company’s pioneering research focuses on signaling... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $297.30
Shares Outstanding(Mil.): 124.39
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 78.94 16.33
EPS (TTM): -- -- --
ROI: -- 2.84 14.66
ROE: -- 4.61 13.99

BRIEF-Rigel Q2 loss per share $0.16

* Rigel announces second quarter 2017 financial results and provides company update

Aug 01 2017

BRIEF-FDA accepts Rigel's NDA for Tavalisse

* FDA accepts Rigel's New Drug Application for Tavalisse™ (fostamatinib disodium) for the treatment of chronic ITP

Jun 19 2017

BRIEF-Rigel Pharmaceuticals enters into amendment to controlled equity offerings sales agreement

* Entered into amendment no. 1 to controlled equity offerings sales agreement, dated august 18, 2015 - SEC filing

May 30 2017

BRIEF-Rigel announces Q1 loss per share $0.13

* Rigel announces first quarter 2017 financial results and provides company update

May 02 2017

BRIEF-Rigel announces Tavaliss as proprietary name for Fostamatinib in the U.S.

* Rigel announces Tavalisse™ as proprietary name for Fostamatinib in the united states

Apr 27 2017

BRIEF-Rigel submits NDA to FDA for fostamatinib in chronic itp

* Rigel submits new drug application to fda for fostamatinib in chronic itp

Apr 17 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF82.95 +0.05
Roche Holding Ltd. (ROG.S) CHF249.00 +2.00
Roche Holding Ltd. (RO.S) CHF249.00 +1.40
Merck & Co., Inc. (MRK.N) $65.60 -0.19
Sanofi SA (SASY.PA) €83.87 +1.57
AstraZeneca plc (AZN.L) 4,768.50 +16.50
Abbott Laboratories (ABT.N) $51.43 -0.46

Earnings vs. Estimates